跳转至内容
Merck
CN

DART®-MS Analysis of Methamphetamine and Amphetamine in Urine Using BioSPME

DART®-MS Analysis of Methamphetamine and Amphetamine in Urine Using BioSPME application for SPME

材料

相关产品

产品编号
说明
价格

(±)-Amphetamine-d5 (deuterium label on ring) solution

100 μg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

(+/-)-苯丙胺标准液 溶液

1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

(±)-甲基苯丙胺-D5标准液 CRM 溶液

100 μg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

(±)-甲基苯丙胺标准液 溶液

1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

CONDITIONS

SPME fiber

BioSPME (SPME LC) Mixed Mode fiber

extraction

10 min with 1 mL sample

desorption process

Direct MS

detector

MS, Full scan 100-500 amu

说明

分析说明

BioSPME was used to determine the presence of methamphetamine and amphetamine in urine samples. Initial screening results can be obtained in less than 60 seconds by analyzing the extracted urine samples on a DART-MS system. By employing a fast and accurate screening method, the number of samples that require chiral separation can be reduced and laboratories can increase throughput and decrease costs associated with their drug screening programs.

法律信息

DART is a registered trademark of JEOL USA, Inc.